• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bearish Sentiment Across The Cannabis Space - Check Full Movers For July 5, 2024

    7/5/24 4:30:05 PM ET
    $CARA
    $CRON
    $EAST
    $GRWG
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $CARA alert in real time by email

    GAINERS:

    • MJ Holdings (OTC:MJNE) shares closed up 36.54% at $0.00
    • Kaya Holdings (OTC:KAYS) shares closed up 22.37% at $0.05
    • Maple Leaf Green World (OTC:MGWFF) shares closed up 11.47% at $0.03
    • Charlottes Web Holdings (OTC:CWBHF) shares closed up 11.19% at $0.18
    • Nextleaf Solutions (OTC:OILFF) shares closed up 6.91% at $0.07
    • Cara Therapeutics (NASDAQ:CARA) shares closed up 6.51% at $0.28
    • Eastside Distilling (NASDAQ:EAST) shares closed up 4.21% at $1.00
    • Mexco Energy (AMEX:MXC) shares closed up 3.51% at $11.86

    LOSERS:

    • Khiron Life Sciences (OTC:KHRNF) shares closed down 99.00% at $1e-06
    • The Flowr (OTC:FLWPF) shares closed down 99.00% at $1e-06
    • Affinor Growers (OTC:RSSFF) shares closed down 45.18% at $0.09
    • Global Compliance (OTC:FUAPF) shares closed down 42.22% at $0.01
    • Cann Gr (OTC:CNGGF) shares closed down 34.91% at $0.02
    • Blueberries Medical (OTC:BBRRF) shares closed down 27.56% at $0.01
    • Target Group (OTC:CBDY) shares closed down 24.65% at $0.00
    • Global Hemp Group (OTC:GBHPF) shares closed down 23.00% at $0.02
    • Leafbuyer Techs (OTC:LBUY) shares closed down 13.25% at $0.02
    • CV Sciences (OTC:CVSI) shares closed down 9.82% at $0.06
    • SOL Glb Inv (OTC:SOLCF) shares closed down 9.02% at $0.04
    • Zoned Props (OTC:ZDPY) shares closed down 8.48% at $0.60
    • Auxly Cannabis Group (OTC:CBWTF) shares closed down 5.86% at $0.02
    • Cansortium (OTC:CNTMF) shares closed down 5.60% at $0.12
    • 1933 Industries (OTC:TGIFF) shares closed down 5.00% at $0.01
    • Cronos Group (NASDAQ:CRON) shares closed down 3.88% at $2.23
    • GrowGeneration (NASDAQ:GRWG) shares closed down 3.65% at $2.11
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed down 3.36% at $0.01
    • cbdMD (AMEX:YCBD) shares closed down 3.31% at $0.56

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CARA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CARA
    $CRON
    $EAST
    $GRWG

    CompanyDatePrice TargetRatingAnalyst
    Cronos Group Inc.
    $CRON
    1/27/2026Buy
    Canaccord Genuity
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$10.00 → $1.00Buy → Hold
    Canaccord Genuity
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Hold
    Needham
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Neutral
    H.C. Wainwright
    GrowGeneration Corp.
    $GRWG
    3/20/2024Outperform → Perform
    Oppenheimer
    GrowGeneration Corp.
    $GRWG
    5/10/2023$4.25 → $4.75Hold → Buy
    Craig Hallum
    Cara Therapeutics Inc.
    $CARA
    3/8/2023$13.00 → $6.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $CARA
    $CRON
    $EAST
    $GRWG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

    CHARLOTTE, N.C., Feb. 17, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD, Bluebird Botanicals, Paw CBD, along with its THC beverage brand Oasis today announced its financial results for the first quarter of fiscal year ended December 31, 2025. cbdMD reported 12% sequential revenue growth and improved liquidity in the first quarter of fiscal 2026, reflecting continued stabilization of the core business and early benefits from recent strategic actions."We a

    2/17/26 4:10:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Cronos Launches New All-in-One Vape, Spinach PUFFERZ™

    TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos"), an innovative global cannabinoid company, announced today the launch of its newest all-in-one (AIO) vape, Spinach PUFFERZ™. The latest innovation under Cronos' Spinach® brand brings together high-quality cannabis infused with liquid diamonds in a convenient all-in-one device. Crafted for modern cannabis consumers who value functionality and design, Spinach PUFFERZ™ offers a seamless way to enjoy high-quality cannabis vape extracts and bold flavors. Every design element was carefully considered to deliver a differentiated experience. Spinach PUFFERZ™ is Cronos' first AIO vape featuring the inc

    2/17/26 7:30:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

    CHARLOTTE, N.C., Feb. 12, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, February 17, 2026, to discuss the company's December 31, 2025 first quarter financial results and business progress. CONFERENCE CALL DETAILS Tuesday, February 17, 2026, 4:20 p.m. Eastern Time USA/Canada: 888-880-3330 Webcast/Webcast Replay link - available through February 17, 2027: https://app.webinar.net/YzX7D4ynvN2 About cbdMD, Inc.

    2/12/26 5:31:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $CARA
    $CRON
    $EAST
    $GRWG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Aiello Stephen bought $221,334 worth of shares (133,334 units at $1.66), increasing direct ownership by 25% to 668,311 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    9/23/25 4:00:54 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    President Salaman Michael bought $103,413 worth of shares (85,465 units at $1.21), increasing direct ownership by 6% to 1,639,313 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    3/20/25 3:54:41 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    CEO Lampert Darren bought $98,340 worth of shares (82,639 units at $1.19), increasing direct ownership by 5% to 1,728,522 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    3/20/25 3:54:01 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $CARA
    $CRON
    $EAST
    $GRWG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Crosnoe Clark R. sold $1,276,842 worth of shares (550,701 units at $2.32) (SEC Form 4)

    4 - cbdMD, Inc. (0001644903) (Issuer)

    12/19/25 9:16:26 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Chief Financial Officer Sanders Gregory Kevin was granted 24,046 shares, increasing direct ownership by 17% to 167,035 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    12/17/25 12:13:12 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    President Salaman Michael was granted 50,000 shares, increasing direct ownership by 3% to 1,739,313 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    12/17/25 12:13:00 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $CARA
    $CRON
    $EAST
    $GRWG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Cronos Group

    Canaccord Genuity initiated coverage of Cronos Group with a rating of Buy

    1/27/26 9:29:20 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Cara Therapeutics downgraded by Stifel with a new price target

    Stifel downgraded Cara Therapeutics from Buy to Hold and set a new price target of $1.00 from $6.00 previously

    6/13/24 7:05:24 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cara Therapeutics downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Cara Therapeutics from Buy to Hold and set a new price target of $1.00 from $10.00 previously

    6/13/24 7:05:04 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRON
    $EAST
    $GRWG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRON
    $EAST
    $GRWG
    SEC Filings

    View All

    SEC Form 10-Q filed by cbdMD Inc.

    10-Q - cbdMD, Inc. (0001644903) (Filer)

    2/17/26 4:06:16 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Mexco Energy Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - MEXCO ENERGY CORP (0000066418) (Filer)

    2/10/26 4:51:41 PM ET
    $MXC
    Oil & Gas Production
    Energy

    SEC Form 10-Q filed by Mexco Energy Corporation

    10-Q - MEXCO ENERGY CORP (0000066418) (Filer)

    2/10/26 4:49:47 PM ET
    $MXC
    Oil & Gas Production
    Energy

    $CARA
    $CRON
    $EAST
    $GRWG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GrowGeneration Corp.

    SC 13G/A - GrowGeneration Corp. (0001604868) (Subject)

    11/12/24 3:53:28 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by GrowGeneration Corp.

    SC 13G/A - GrowGeneration Corp. (0001604868) (Subject)

    11/4/24 11:51:39 AM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    SEC Form SC 13D filed by Cara Therapeutics Inc.

    SC 13D - Cara Therapeutics, Inc. (0001346830) (Subject)

    10/30/24 4:21:50 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRON
    $EAST
    $GRWG
    Leadership Updates

    Live Leadership Updates

    View All

    Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

    TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the "Meeting"), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company's definitive proxy statement dated April 25, 2025 was elected as a director of the Company, with each director receiving in excess of 92.3% of the votes cast in favor of his or her election. The detailed results of the vote for the e

    6/23/25 5:30:00 PM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

    Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA) (the "Company" or "cbdMD") one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs and emerging THC-infused seltzer brand Herbal Oasis announced today that at the Company's annual meeting of shareholders held on April 10, 2025, that its Common Stock holders and 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") holders approved the automatic conversion (the "Conversion") of shares of the Company's Preferred Stock into shares of the Comp

    4/10/25 5:57:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Cronos Appoints Anna Shlimak as Chief Financial Officer

    TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Ms. Shlimak, who previously served as Cronos' Chief Strategy Officer, will succeed James Holm who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition. Ms. Shlimak has been an integral part of Cronos' leadership team for the last seven years, playing a key role in shaping the Company's strategy, operational efficiencies, and engagement with the financial and

    3/19/25 7:30:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $CRON
    $EAST
    $GRWG
    Financials

    Live finance-specific insights

    View All

    cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

    CHARLOTTE, N.C., Feb. 17, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD, Bluebird Botanicals, Paw CBD, along with its THC beverage brand Oasis today announced its financial results for the first quarter of fiscal year ended December 31, 2025. cbdMD reported 12% sequential revenue growth and improved liquidity in the first quarter of fiscal 2026, reflecting continued stabilization of the core business and early benefits from recent strategic actions."We a

    2/17/26 4:10:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

    CHARLOTTE, N.C., Feb. 12, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, February 17, 2026, to discuss the company's December 31, 2025 first quarter financial results and business progress. CONFERENCE CALL DETAILS Tuesday, February 17, 2026, 4:20 p.m. Eastern Time USA/Canada: 888-880-3330 Webcast/Webcast Replay link - available through February 17, 2027: https://app.webinar.net/YzX7D4ynvN2 About cbdMD, Inc.

    2/12/26 5:31:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

    TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be arch

    2/12/26 7:30:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care